C L Finstad
Overview
Explore the profile of C L Finstad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
628
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Papandreou C, Bogenrieder T, Finstad C, Freeman R, Chao M, Albino A, et al.
Urol Oncol
. 2011 Jan;
4(6):210-7.
PMID: 21227260
Reduced expression of the low-affinity p75 neurotrophin receptor (p75(NTR)) occurs in prostate epithelial cells during malignant transformation. Recent studies indicating that the p75(NTR) can transduce signals that induce apoptosis suggest...
2.
Federici M, Kudryashov V, Saigo P, Finstad C, LLOYD K
Int J Cancer
. 1999 Apr;
81(2):193-8.
PMID: 10188718
Expression of blood group-related carbohydrate antigens was examined in frozen sections from a series of ovarian carcinomas of different histological types using an indirect immunoperoxidase technique. Antigenic specificities belonging to...
3.
Nanus D, Bogenrieder T, Papandreou C, Finstad C, Lee A, Vlamis V, et al.
Int J Oncol
. 1998 Jul;
13(2):261-7.
PMID: 9664120
The gp160 human kidney differentiation antigen is identical to human aminopeptidase A (APA), a zinc-dependent cell-surface metallopeptidase which hydrolyzes peptides with N-terminal acidic residues. GP160/APA is constitutively expressed by proximal...
4.
Papandreou C, Usmani B, Geng Y, Bogenrieder T, Freeman R, Wilk S, et al.
Nat Med
. 1998 Jan;
4(1):50-7.
PMID: 9427606
Neutral endopeptidase 24.11 (NEP) is a cell-surface enzyme expressed by prostatic epithelial cells that cleaves and inactivates neuropeptides implicated in the growth of androgen-independent prostate cancer (PC). We report that...
5.
Bogenrieder T, Finstad C, Freeman R, Papandreou C, Scher H, Albino A, et al.
Prostate
. 1997 Dec;
33(4):225-32.
PMID: 9397193
Background: Cell-surface peptidases are ectoenzymes which regulate the access of bioactive peptides to their receptors on cell membranes. Abnormalities in their expression and function result in altered peptide activity which...
6.
Olson S, Finstad C, Harlap S, Kurian L, Saigo P, Barakat R
Cancer Epidemiol Biomarkers Prev
. 1997 Oct;
6(10):815-7.
PMID: 9332764
We studied 54 patients diagnosed with endometrial cancer between 1981 and 1994 following a diagnosis of breast cancer. We used a case-case analysis, comparing tumors with and without overexpression of...
7.
Finstad C, LLOYD K, Federici M, Divgi C, Venkatraman E, Barakat R, et al.
Clin Cancer Res
. 1997 Aug;
3(8):1433-42.
PMID: 9815829
Our objective was to quantify the targeting of the monoclonal antibody (mAb) MX35 F(ab')2 to micrometastatic epithelial ovarian cancer. This mAb detects a Mr 95,000 glycoprotein with homogeneous distribution on...
8.
Oosterkamp H, Scheiner L, Stefanova M, LLOYD K, Finstad C
Int J Cancer
. 1997 Jul;
72(1):87-94.
PMID: 9212228
Mucins, including MUC-1, are generally considered to be products of epithelial tissues and of their tumors. To examine the possible expression of MUC-1 in other cell types, a panel of...
9.
Desloge R, Carew J, Finstad C, Steiner M, Sassoon J, Levenson M, et al.
Am J Otol
. 1997 Mar;
18(2):155-9.
PMID: 9093669
Hypothesis: The hypothesis tested in this article is that if cholesteatomas are a low-grade squamous cell neoplasm, then evidence of genetic instability, in the form of abnormal or aneuploid amounts...
10.
Desloge R, Finstad C, Sassoon J, Han J, Parisier S, Albino A
Otolaryngol Head Neck Surg
. 1997 Jan;
116(1):58-63.
PMID: 9018259
Cholesteatoma is a destructive process involving an accumulation of desquamated keratin arising from squamous epithelium that pathologically has invaded the middle ear or mastoid process. The clinical hallmarks of cholesteatomas,...